For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that are associated with activation of Abelson Tyrosine Kinases (c-Abl kinases), announces it has ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

Discover expert dog health guides covering nutrition, exercise, common conditions, preventive care, and mental wellness.

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Tecvayli monotherapy significantly reduces disease progression and mortality in relapsed or refractory multiple myeloma patients, showing a 71% reduction in progression risk and 40% in mortality risk.

The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first smart MDI system to automatically integrate insulin dosing and glucose data ...

Smoldering multiple myeloma is an asymptomatic, precancerous condition with abnormal plasma cells and elevated monoclonal protein levels. Smoldering multiple myeloma is a complex, intermediary stage ...

Researchers have proposed a novel integrated framework to understand the complex progression of autoimmune skin diseases. A ...

Carla is a writer from Peñuelas, Puerto Rico, now based in Atlanta. She’s an Emory alum with both a BA and MA in English, but more importantly, she’s a Pisces with lots of opinions about video games.